University Urology Associates
New York, New York, United States
Urologist in New York City, New York
215 Lexington Ave 21st floor, New York, NY 10016
About University Urology Associates
"Vasectomy Expert and NYC Urologist Jed Kaminetsky, MD offers the latest treatment and technologies to address urological concerns; enlarged prostate, overactive bladder, urinary tract infections, vasectomies - and more"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ferring Pharmaceuticals
7
Clarus Therapeutics, Inc.
3
Endo Pharmaceuticals
3
Pfizer
3
AEterna Zentaris
2
Repros Therapeutics Inc.
2
Spectrum Pharmaceuticals, Inc
2
Astellas Pharma Inc
1
Bavarian Nordic
1
Ethicon Endo-Surgery
1
GTx
1
Clinical Trials at University Urology Associates
During the past decade, University Urology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 17 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
2003-10-01
2007-11-01
Completed
1,200
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
2007-03-01
2009-12-01
Terminated
667
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
2007-04-01
2012-01-01
Completed
802
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
2007-05-01
2008-02-01
Completed
799
An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
2007-12-01
2010-05-01
Completed
554
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
2008-03-01
2009-08-01
Completed
528
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
2008-06-01
2009-08-01
Completed
17
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
2008-08-01
2009-07-01
Completed
511
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Urology Associates" #1 sponsor was "Ferring Pharmaceuticals" with 7 trials, followed by "Clarus Therapeutics, Inc." with 3 trials
sponsored, "Endo Pharmaceuticals" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "AEterna Zentaris"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Urology Associates"
#1 collaborator was "Allergan" with 1 trials as a collaborator, "Data & Inference, Inc." with 1 trials as a collaborator, "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "PharmaNet" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at University Urology Associates
According to Clinical.Site data, the most researched conditions in "University Urology Associates" are
"Nocturia" (4 trials), "Prostate Cancer" (4 trials), "Male Hypogonadism" (3 trials), "Peyronie's Disease" (3 trials) and "Adult Male Hypogonadism" (2 trials). Many other conditions were trialed in "University Urology Associates" in a lesser frequency.
Clinical Trials Intervention Types at University Urology Associates
Most popular intervention types in "University Urology Associates" are "Drug" (24 trials), "Biological" (5 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "AA4500" (3 trials), "Oral testosterone undecanoate" (3 trials), "Apaziquone" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University Urology Associates
The vast majority of trials in "University Urology Associates" are
21 trials for "Male" genders and 10 trials for "All" genders.
Clinical Trials Status at University Urology Associates
Currently, there are NaN active trials in "University Urology Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in University Urology Associates,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University Urology Associates, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".